
TrkB agonist, 7,8-dihydroxyflavone, reduces the clinical and pathological severity of a murine model of multiple sclerosis
Keywords: EAE; Experimental autoimmune encephalomyelitis; MS; Multiple Sclerosis; DHF; 7, 8-dihydroxyflavone; TrkB; Tropomyosin Related Kinase B receptor; MOG; Myelin oligodendrocyte glycoprotein; CNS; Central nervous system; BBB; Blood brain barrier; Experimental